Qin, Huanlong
Ji, Jiafu
Miao, Yi
Liu, Tong
Zhao, Dongbing
Jia, Zhenyi
Jiang, Jun
Liu, Jiang
Li, Qiang
Ji, Xi
Fu, Weihua
Lou, Donghua
Xia, Wenyu
Li, Ning http://orcid.org/0000-0002-6949-9909
Article History
Accepted: 5 January 2022
First Online: 19 June 2022
Declarations
:
: WYX is general manager of Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., the sponsor of this study. Other authors declare no conflicts of interest.
: The study was approved by the research ethics committee of each hospital.